Endocrine Today Current Issue

The following articles appeared in the print edition of Endocrine Today.

Table of Contents

• Clinicians seek better outcomes for women with CVD
• Practice in Focus: Large, single-specialty practice offers freedom to endocrinologists
• Doing well on the gel: Declining testosterone levels on treatment pose challenge Ronald Tamler, MD, PhD, MBA
• FDA accepts new drug application for empagliflozin, metformin combo therapy
• Birth weight could factor into high diabetes rates in black population
• Blacks with diabetes at higher risk for amputation, PAD complications than whites
• Lasers could provide non-invasive method for glucose measurement
• Low levels of DHEA predicted CHD risk in elderly men
• Mortality risk related to high BMI similar for blacks, whites
• MsFLASH: Success, potential in treating bothersome menopause symptoms
• New report highlights osteoporosis prevalence in men, calls for action
• Overweight, obesity rates plateau for Ireland's primary school-aged children
• Polyunsaturated fats may counter cardiometabolic effects of weight gain in healthy adults
• Postnatal growth may identify infants genetically predisposed to obesity
• Recommendations released for obesity-related conditions in children
• Vagal nerve block improved weight loss for patients with morbid obesity
• Vitamin D deficiency, type 2 diabetes development lack causal relation
• Diabetes increased risk for major osteoporotic, hip fracture
• Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear
• Exploration of devices to treat resistant hypertension in progress
• FDA approves remote mobile communications device for CGM
• Fixed-dose empagliflozin/linagliptin combinations improved HbA1c in type 2 diabetes
• Lower estradiol, SHBG levels related to ectopic CV fat volumes in women at midlife
• Nonhormonal menopause treatment did not inhibit enzyme related to tamoxifen conversion
• Novel bioidentical estradiol vaginal capsule shows promise in pilot study